Neurological diseases are a big deal. They're the second biggest killer worldwide. Diseases like Huntington's, Alzheimer's, and Parkinson's are becoming more common as people live longer. This is where CRISPR comes in. CRISPR is a powerful tool for editing genes, and it's been a game-changer in the
Ken Griffin, the head of Citadel, recently spoke out about the impact of President Trump's aggressive trade tactics. He believes that Trump's strong words are causing harm. Griffin thinks that these words make it hard for business leaders and policymakers to trust the U. S. as a reliable trading par
In a surprising turn of events, a federal judge recently stepped in to halt a controversial plan. The judge ordered the government to keep funding for hospitals that provide gender-transition treatments for young people under 19. This decision came after a lawsuit filed by six transgender individual
CVS Health, a company that had a rough 2024, is showing signs of a comeback. Investors are taking notice, especially after the company's impressive fourth-quarter earnings report. Shares of CVS have surged by over 45% this year, outperforming rivals like Walgreens, which has only seen a 3% increase.
Medical schools are under fire. Not from a new virus or a natural disaster. But from political attacks. These attacks are targeting programs that promote diversity, equity, and inclusion. These programs are crucial for creating a medical workforce that reflects the diverse population it serves. But
Kids often face tough times early in life. This is a fact. But what if they could learn to overcome these challenges? This is where resilience comes in. Resilience is like a superhero power that helps kids deal with tough situations. But can this power be taught? That's the big question. Resear
COVID-19 sped up the race to get healthcare technology up and running. The pandemic forced healthcare to quickly adopt new technologies to keep up with healthcare delivery, making everything move faster. Usually, getting these systems in place is tough due to complicated tech and human factors. Tec
Japan has been in a tough spot when it comes to HPV vaccinations. Even after the government greenlit the vaccination program in 2022, the number of people getting vaccinated is still alarmingly low. This is a big problem for public health. Why are so many people still hesitant? Misinformation has s
Kidney organs made in labs could be a game-changer for people with kidney diseases. Think about it— having a new kidney grown just for you, no waiting lists or ethical dilemmas. This could be the future, but we're not there yet. Scientists are working hard to make these lab-made kidneys work just li
The world is getting older. People are living longer. This means there are more older adults who need care. The places that care for them, like nursing homes, are having a tough time. They can't keep enough personal care workers. Workers are leaving too fast, and it's a big problem. This review look
